Acadia Healthcare Company Management
Management criteria checks 3/4
Acadia Healthcare Company's CEO is Chris Hunter, appointed in Apr 2022, has a tenure of 2.67 years. total yearly compensation is $7.40M, comprised of 13.5% salary and 86.5% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $5.26M. The average tenure of the management team and the board of directors is 1.9 years and 6.8 years respectively.
Key information
Chris Hunter
Chief executive officer
US$7.4m
Total compensation
| CEO salary percentage | 13.5% |
| CEO tenure | 2.7yrs |
| CEO ownership | 0.1% |
| Management average tenure | 1.9yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
It's Down 29% But Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Could Be Riskier Than It Looks
Nov 02
Returns On Capital Are Showing Encouraging Signs At Acadia Healthcare Company (NASDAQ:ACHC)
Oct 27Acadia Healthcare Company (NASDAQ:ACHC) Takes On Some Risk With Its Use Of Debt
Oct 06Acadia Healthcare: Further Scrutiny Of Suspect Practices Will Take Time To Resolve
Sep 27Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Popularity With Investors Is Clear
Sep 14Acadia Healthcare Company (NASDAQ:ACHC) Might Have The Makings Of A Multi-Bagger
Jul 11Is Acadia Healthcare Company (NASDAQ:ACHC) Using Too Much Debt?
Jun 16Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Shareholders Might Be Looking For Exit
May 24Acadia Healthcare: M&A Strategies Facilitate Market Expansion
May 03The Return Trends At Acadia Healthcare Company (NASDAQ:ACHC) Look Promising
Mar 21Acadia Healthcare Company (NASDAQ:ACHC) Seems To Use Debt Quite Sensibly
Feb 12Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Not Quite Adding Up
Dec 27We Like These Underlying Return On Capital Trends At Acadia Healthcare Company (NASDAQ:ACHC)
Dec 06What Does Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Indicate?
Oct 23These 4 Measures Indicate That Acadia Healthcare Company (NASDAQ:ACHC) Is Using Debt Reasonably Well
Sep 13Acadia Healthcare Company (NASDAQ:ACHC) Is Experiencing Growth In Returns On Capital
Aug 23Do Acadia Healthcare Company's (NASDAQ:ACHC) Earnings Warrant Your Attention?
Jul 24Is There Now An Opportunity In Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Jul 10Is Acadia Healthcare Company (NASDAQ:ACHC) A Risky Investment?
May 29Returns On Capital Are Showing Encouraging Signs At Acadia Healthcare Company (NASDAQ:ACHC)
May 15With EPS Growth And More, Acadia Healthcare Company (NASDAQ:ACHC) Makes An Interesting Case
Apr 16What Is Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Doing?
Apr 03We Think Acadia Healthcare Company (NASDAQ:ACHC) Can Stay On Top Of Its Debt
Feb 19Acadia Healthcare Company (NASDAQ:ACHC) Is Experiencing Growth In Returns On Capital
Feb 05With EPS Growth And More, Acadia Healthcare Company (NASDAQ:ACHC) Makes An Interesting Case
Jan 08When Should You Buy Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Dec 26Is Acadia Healthcare Company (NASDAQ:ACHC) A Risky Investment?
Nov 16Returns At Acadia Healthcare Company (NASDAQ:ACHC) Are On The Way Up
Oct 24Here's Why We Think Acadia Healthcare Company (NASDAQ:ACHC) Is Well Worth Watching
Sep 28What Is Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Doing?
Sep 14We Think Acadia Healthcare Company (NASDAQ:ACHC) Can Stay On Top Of Its Debt
Aug 17Acadia Healthcare Q2 2022 Earnings Preview
Jul 26Investors Met With Slowing Returns on Capital At Acadia Healthcare Company (NASDAQ:ACHC)
Jul 25Acadia Healthcare: Capitalizing On Major Mental Health Trend
Jul 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$281m |
| Jun 30 2024 | n/a | n/a | -US$5m |
| Mar 31 2024 | n/a | n/a | -US$11m |
| Dec 31 2023 | US$7m | US$1m | -US$22m |
| Sep 30 2023 | n/a | n/a | -US$18m |
| Jun 30 2023 | n/a | n/a | US$271m |
| Mar 31 2023 | n/a | n/a | US$278m |
| Dec 31 2022 | US$7m | US$1m | US$273m |
Compensation vs Market: Chris's total compensation ($USD7.40M) is about average for companies of similar size in the US market ($USD6.57M).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Hunter (56 yo)
2.7yrs
Tenure
US$7,404,606
Compensation
Mr. Christopher Howal Hunter, also known as Chris, serves as Chief Executive Officer and Director at Acadia Healthcare Company, Inc. since April 11, 2022. He serves as an Independent Director of AfterNext...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.7yrs | US$7.40m | 0.14% $ 5.3m | |
| Chief Financial Officer | 1.4yrs | US$7.01m | 0.072% $ 2.7m | |
| Executive VP | 1.4yrs | US$2.95m | 0.034% $ 1.3m | |
| Advisor | less than a year | US$2.86m | 0.13% $ 4.7m | |
| Chief Operating Officer | less than a year | no data | 0.028% $ 1.0m | |
| Chief Information Officer | 1.9yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief Marketing Officer | 1.8yrs | no data | no data | |
| Senior Vice President of Strategic Affairs | 5.9yrs | no data | no data | |
| Chief Strategy Officer | 2.9yrs | no data | no data | |
| Senior Vice President of Business Transformation | 2.1yrs | no data | no data | |
| Operations Group President | no data | no data | no data |
1.9yrs
Average Tenure
54yo
Average Age
Experienced Management: ACHC's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.7yrs | US$7.40m | 0.14% $ 5.3m | |
| Independent Chairman | 19yrs | US$401.97k | 0.71% $ 26.6m | |
| Independent Director | 11.9yrs | US$299.00k | 0.042% $ 1.6m | |
| Independent Director | 13.7yrs | US$299.50k | 0.084% $ 3.2m | |
| Independent Director | 5yrs | US$262.00k | 0.024% $ 906.2k | |
| Independent Director | 8.6yrs | US$297.00k | 0.032% $ 1.2m | |
| Independent Director | 12.9yrs | US$289.50k | 0.052% $ 2.0m | |
| Independent Director | 2.5yrs | US$256.97k | 0.0087% $ 326.7k | |
| Independent Director | 1.2yrs | US$259.52k | 0.0049% $ 184.2k | |
| Independent Director | 4.2yrs | US$289.50k | 0.016% $ 598.6k |
6.8yrs
Average Tenure
62.5yo
Average Age
Experienced Board: ACHC's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 22:51 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Acadia Healthcare Company, Inc. is covered by 28 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Ishan Majumdar | Baptista Research |
| Sarah James | Barclays |